Daily Market Summary
Vaxart, Inc. (VXRT) Obtains Clearance from the FDA to Begin COVID-19 vaccine candidate Trials
The Biotech firm moves one step forward to begin Phase 1 trials for COVID-19 vaccine candidate. Vaxart is ready to conduct trials upon healthy adults